New Pennsylvania facility strengthens Endress+Hauser’s reach in life sciences, pharma
For life sciences, pharmaceutical manufacturing, and chemical processing operations across the mid-Atlantic region, instrument support and process expertise just got a lot closer. Endress+Hauser has inaugurated its new Edgmont, Pennsylvania campus, opening a 100,000-square-foot facility that places it under one roof with Eastern Controls Inc. (ECI) — its sales representative for the eastern U.S. and a 55-year veteran of the region’s process industries.
The co-location is more than a real estate decision. For plant managers, instrumentation engineers and procurement teams in pharma, biotech, and specialty chemicals, it signals a committed, long-term infrastructure investment from one of the world’s leading suppliers of process measurement and automation technology.
“By bringing both together here in Edgmont, we can support customers faster, better and more comprehensively — from life sciences and chemicals, to water, energy and food and beverage,” said Peter Selders, CEO of Endress+Hauser, addressing guests, customers, and local officials at the ceremony.
Regional hub built for industry demands
Life sciences and chemical processing are among the most demanding environments for process instrumentation. Stringent regulatory requirements, validation obligations, the need for traceable calibration, and the criticality of uptime make local expertise and rapid-response support not a convenience but a competitive necessity. The Edgmont campus is designed to address exactly that.
Todd Lucey, general manager of Endress+Hauser USA, described the daily operational value the model delivers. “What we see every day now is the collaboration opportunities — having Endress+Hauser people and the rep people meeting together on a daily basis,” he said. “You get to do talent development with the innovation studio, community curriculum and education programs. It just puts a bond that you can’t put a price tag on.”
Lucey identified life sciences as one of the three primary growth industries the campus will serve, alongside water and wastewater and chemicals. That focus is deliberate: the mid-Atlantic corridor is home to a dense concentration of pharmaceutical manufacturers, biotech facilities and specialty chemical producers for whom measurement accuracy, regulatory compliance and supply chain reliability are non-negotiable.
Hands-on validation, process training for technical buyers
A centerpiece of the Edgmont campus is its Process Training Unit — the seventh in Endress+Hauser’s U.S. network — which gives customers direct, physical access to the full range of instrumentation before committing to a purchase or a qualification program.
“One of the things we really love doing is inviting customers to visit and really touch and feel, and directly operate the equipment,” said Cliff McLaughlin, president of Eastern Controls. “By having a process training unit with control valves, actuators, gas detection and all the Endress+Hauser instrumentation, customers can touch and feel the products before they make an investment. On top of that, we can help them learn how to use them — starting with the fundamentals of instrumentation, through particular technologies, all the way to device-specific operation.”
For engineers in pharma and chemical processing who must document instrument performance as part of IQ/OQ/PQ validation or process hazard analyses, this kind of pre-purchase evaluation capability — available locally, from people who know the application — reduces procurement risk and accelerates commissioning timelines.
Selders reinforced the strategic importance of the training network. “This is not only good for our customers, but also important for our industry,” he said.
Decades of application knowledge, now consolidated
Eastern Controls has served the mid-Atlantic process industries since 1969, built on what McLaughlin describes as a relationships-first philosophy inherited from his parents, who founded the company with a $5,000 loan. ECI’s deep familiarity with the region’s pharmaceutical plants, chemical facilities and water infrastructure means customers dealing with complex application questions — hygienic flow measurement, pressure transmitters for hazardous areas, level instrumentation in API manufacturing — have access to experienced applications support, not just a catalog.
The relationship between ECI and Endress+Hauser began in 2015, after a site visit to the manufacturer’s Indiana production facility left a strong impression. “We saw a world-class, absolutely spotless, highly automated manufacturing facility,” McLaughlin recalled. “They were considering adding a rep company in the Philadelphia area, and they asked if we were interested, and we said yes.”
That partnership has grown substantially. Combined with partner organizations George Booth and PCI in a broader regional rep network, ECI now represents approximately $130 million in Endress+Hauser business — making it the manufacturer’s third-largest rep relationship in the U.S.
Long-term commitment, not short-term contracts
For customers in regulated industries, supplier stability matters. The Endress+Hauser-ECI co-location model is an explicit statement of long-term commitment — and one that Lucey says is virtually unprecedented in the instrumentation industry.
“It’s very unique in the industry,” Lucey said. “No one that I’m aware of has done it — bringing an independent sales representative together in a co-facilitation like this.” He acknowledged that the arrangement challenges conventional thinking: “A lot of people stay away from these things because of the brands. But our commitment to the reps is generational. We have a different view than just a 30-day contract view. This is a partnership that we have for life.”
Steven Endress, president of the supervisory board and a third-generation member of the founding family, connected that philosophy directly to the company’s ownership structure. “One of the privileges of family ownership is that you can look beyond the next quarter, beyond the next business cycle,” he said. “We can think in terms of generations. We ask ourselves not only what is right for today, but what will strengthen our company and our people for decades to come.”
He described the Edgmont campus as “a clear expression of that long-term thinking — not because of its size or the technology inside it, but because it reflects belief in the future, belief in people, belief in relationships.”
The Edgmont opening follows a similar inauguration at Endress+Hauser’s Greenwood, Ind., facility earlier in the same week, and joins an existing co-located facility in Houston, Texas.
For life sciences, pharma and chemical processing operations in the mid-Atlantic region, the message from Edgmont is straightforward: Endress+Hauser is investing for the long term — in people, in facilities and in the kind of close customer relationships that make the difference in technically demanding, highly regulated environments.
